bioAffinity to join NC event for lung cancer awareness and early detection.
The company will showcase its CyPath Lung test at the Lung Cancer Initiative of NC's event, emphasizing early detection for curative outcomes.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed